See the DrugPatentWatch profile for Fenofibrate
Fenofibrate is a medication used to lower cholesterol and triglycerides in the blood. It belongs to a class of drugs called fibrates, which work by increasing the activity of an enzyme that breaks down fats in the liver. This can help reduce the risk of pancreatitis in patients with high triglyceride levels and may also have a beneficial effect on HDL ("good") cholesterol.
How does fenofibrate work to lower cholesterol?
Fenofibrate works by activating peroxisome proliferator-activated receptors (PPARs) in the body [1]. These receptors play a role in regulating lipid metabolism. By activating PPARs, fenofibrate influences gene expression, leading to increased breakdown of triglycerides and a reduction in LDL ("bad") cholesterol [1]. It also tends to increase HDL cholesterol levels [1].
What conditions is fenofibrate prescribed for?
Fenofibrate is primarily prescribed for patients with hyperlipidemia, a condition characterized by abnormally high levels of fats (cholesterol and triglycerides) in the blood [1]. It is particularly useful for lowering very high triglyceride levels, which can be a risk factor for pancreatitis [1]. It is often used in conjunction with diet and exercise, and sometimes with statins, to manage dyslipidemia [1].
What are the common side effects of fenofibrate?
Common side effects of fenofibrate can include gastrointestinal issues such as nausea, stomach pain, and diarrhea. Other potential side effects include headache, back pain, and respiratory tract infection. Less common but more serious side effects can involve liver function abnormalities, muscle pain (myopathy), and an increased risk of gallstones [1].
How does fenofibrate compare to other cholesterol-lowering medications?
Fenofibrate belongs to the fibrate class, which differs from statins, another common class of cholesterol-lowering drugs. While statins primarily focus on lowering LDL cholesterol, fenofibrates are more effective at lowering triglycerides and raising HDL cholesterol [1]. In some cases, fenofibrate may be used in combination with a statin for patients who require comprehensive lipid management [1].
When does fenofibrate's patent exclusivity expire?
Drug patent information, including expiry dates for fenofibrate, can be found on resources like DrugPatentWatch.com [2]. Patent exclusivity is crucial as it grants the drug innovator a period of market protection. Once patents expire, generic versions of the medication can become available, often leading to lower prices.
Where can I find more detailed information on fenofibrate patents?
Detailed information on fenofibrate patents, including their status and expiry timelines, is available through specialized databases and resources. DrugPatentWatch.com offers comprehensive data on drug patents, which can be valuable for understanding market exclusivity and the potential introduction of generic alternatives [2].
What are the regulatory considerations for fenofibrate?
Fenofibrate, like all medications, is subject to rigorous regulatory oversight by agencies such as the U.S. Food and Drug Administration (FDA). Approval requires demonstration of safety and efficacy through clinical trials. Ongoing monitoring ensures that the drug continues to meet these standards. Regulatory bodies also oversee the approval process for generic versions of fenofibrate once patent exclusivity has ended.